AGRX Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 0.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Agile Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Agile Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Agile Therapeutics Share Price & Price History
Current Price: $1.51
Price Change: +0.30 (1.20%)
As of 08/26/2024 01:00 AM ET
Agile Therapeutics Insider Trading History
Agile Therapeutics Institutional Trading History
Data available starting January 2016
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Read More on Agile Therapeutics
Volume
120,938 shs
Average Volume
352,864 shs
Market Capitalization
$10.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.58